Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Paxmedica Inc (OP: PXMD ) 0.1168 +0.0096 (+8.96%) Streaming Delayed Price Updated: 2:46 PM EDT, Nov 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 27,273 Open 0.1172 Bid (Size) N/A (0) Ask (Size) N/A (0) Prev. Close 0.1072 Today's Range 0.1000 - 0.1172 52wk Range 0.0610 - 0.5250 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Siblings of Autistic Kids Have Sevenfold Higher Risk of Autism October 11, 2024 Via Investor Brand Network Study Links Iron Deficiency to Disturbed Sleep Among Autism, ADHD Patients September 23, 2024 Via Investor Brand Network Performance YTD -68.43% -68.43% 1 Month -16.57% -16.57% 3 Month -49.26% -49.26% 6 Month -57.53% -57.53% 1 Year -68.43% -68.43% More News Read More BioMedNewsBreaks — PaxMedica Inc. (PXMD) Announces Immediate Exercise of Warrants to Total Approximately $884K September 03, 2024 Via Investor Brand Network PaxMedica Secures Immediate Exercise of Warrants September 03, 2024 Via ACCESSWIRE Yale Study Unravels Autism, Brain Growth Patterns August 30, 2024 Via Investor Brand Network PaxMedica Reports First Patient Treated with PAX-101 for Fatal African Sleeping Sickness Infection August 27, 2024 Via ACCESSWIRE Women with Autism Have Higher Odds of Being Misdiagnosed with BPD July 17, 2024 Via Investor Brand Network BioMedNewsBreaks – PaxMedica Inc. (NASDAQ: PXMD) Provides Update on Its Response to Extraordinary Request to Provide PAX-101 to Malawi August 27, 2024 Via Investor Brand Network Topics Economy Exposures Supply Chain BioMedNewsBreaks — PaxMedica Inc. (PXMD) Committed to Global Health, Potential Positive Impact of PAX-101 August 22, 2024 Via Investor Brand Network Exposures Product Safety BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Preparing for NDA Submission for Leading Drug Candidate August 05, 2024 Via Investor Brand Network Exposures Product Safety Study Shows Autism More Prevalent in Kids Living in Congested Areas July 31, 2024 Via Investor Brand Network PaxMedica Inc. (NASDAQ: PXMD) Developing Treatments for Underserved Neurological Disorders July 25, 2024 Via Investor Brand Network Exposures Product Safety BioMedNewsBreaks — PaxMedica Inc. (PXMD) Intensifying Efforts to Achieve Significant Program Milestones July 01, 2024 Via Investor Brand Network Exposures Product Safety New Research Suggests More Intervention May Not Increase Benefits for Autistic Kids July 01, 2024 Via Investor Brand Network BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Marks Major Milestone in Preparations for NDA Submission, Global Suramin Supply June 13, 2024 Via Investor Brand Network Topics Supply Chain Exposures Supply Chain Researchers Say Brain ‘Overgrowth’ Could Contribute to Autism Development June 12, 2024 Via Investor Brand Network Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.